Association of Travel Time With Definitive Prostate Cancer Treatment: A United States Registry Cohort Study
Cancer Medicine · 2026
DOI: 10.1002/cam4.72376 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Filippo Dagnino und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Travel, Health Services Accessibility. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute (NCI) Parent organization: National Institutes of Health (NIH) Program: Surveillance, Epidemiology, and End Results (SEER) Program Aw…, JG CDC HHS, Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Purpose
Prostate cancer (PCa) mortality disparities are partly driven by unequal access to care. Transportation barriers may limit access to definitive treatment. We studied how driving travel time affects receipt of definitive PCa treatment. Materials and Methods We conducted a cohort study of men with non‐metastatic PCa (2000–2015; follow‐up through 2018) across the metropolitan area cancer registries of seven US states. Travel time was estimated using Google Maps isochrones representing driving time thresholds to reach the hospital appended to geomasked residential addresses. Outcomes were “no treatment,” “radical surgery,” or “radiotherapy”. Covariate‐adjusted multinomial logistic regression with interaction terms assessed modification by sociodemographic factors.
Results
The study included 132,939 men, of whom 37.0% received no treatment, 41.0% underwent surgery, and 22.0% received radiotherapy. Longer driving time (≥ 90 min vs. < 30 min) was associated with higher radical prostatectomy (aOR: 1.08, 95% CI: 1.03, 1.12), but lower radiotherapy (0.72, 95% CI: 0.69–0.76). Subgroup analyses revealed higher surgery associated with longer driving times among those in nSES Q1 (aOR: 1.33, 95% CI: 1.21–1.45) vs. Q5 (aOR: 0.94, 95% CI: 0.86–1.04), those in low (aOR: 1.16, 95% CI: 1.09–1.24) vs. high (aOR: 1.03, 95% CI: 0.98–1.09) population density areas, and those with regional (aOR: 1.30, 95% CI: 1.14–1.48) vs. localized (aOR: 1.05, 95% CI: 1.00–1.09) disease. Longer driving time was mostly associated with lower odds of radiotherapy across sociodemographic subgroups.
Conclusions
Higher travel time was associated with lower radiotherapy receipt, but higher surgery use in deprived and rural patients, warranting further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Center for Surgery and Public Health, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Department of Urology, Humanitas Research Hospital-IRCCS, Milan, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- Department of Urology, Medical University of Vienna, Vienna, Austria.
- Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Filippo Dagnino, Stephan Korn, Zhiyu Qian, Daniel Stelzl, Klara Pohl, Mei-Chin Hsieh, Brenda Y Hernandez, Andrea Piccolini, Stuart R Lipsitz, Amanda Reich, Joel S Weissman, Alexander P Cole, Quoc-Dien Trinh, Hari S Iyer
Förderung
- National Cancer Institute (NCI) Parent organization: National Institutes of Health (NIH) Program: Surveillance, Epidemiology, and End Results (SEER) Program Aw…
- JG CDC HHS
- Congressionally Directed Medical Research Programs
- NCI NIH HHS
- NIH HHS
- CLC NIH HHS
- NIEHS NIH HHS
- ORFDO NIH HHS
Zitieren
APA
Dagnino, F., Korn, S., Daniels, D., Qian, Z., Stelzl, D., Zurl, H., Pohl, K., Hsieh, M. C., Hernandez, B. Y., Piccolini, A., Lughezzani, G., Buffi, N. M., Lipsitz, S. R., Reich, A., Weissman, J. S., Cole, A. P., Trinh, Q. D., & Iyer, H. S. (2026). Association of Travel Time With Definitive Prostate Cancer Treatment: A United States Registry Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.72376
Vancouver
Dagnino F, Korn S, Daniels D, Qian Z, Stelzl D, Zurl H, et al. Association of Travel Time With Definitive Prostate Cancer Treatment: A United States Registry Cohort Study. Cancer Medicine. 2026. doi:10.1002/cam4.72376
BibTeX
@article{Dagnino2026,
author = {Dagnino, Filippo and Korn, Stephan and Daniels, Danesha and Qian, Zhiyu and Stelzl, Daniel and Zurl, Hanna and Pohl, Klara and Hsieh, Mei-Chin and Hernandez, Brenda Y and Piccolini, Andrea and Lughezzani, Giovanni and Buffi, Nicolò M and Lipsitz, Stuart R and Reich, Amanda and Weissman, Joel S and Cole, Alexander P and Trinh, Quoc-Dien and Iyer, Hari S},
title = {Association of Travel Time With Definitive Prostate Cancer Treatment: A United States Registry Cohort Study},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72376}
}
EUVIMED